Glycogen storage disease due to LAMP-2 deficiency
General Information (adopted from Orphanet):
Synonyms, Signs: |
PSEUDOGLYCOGENOSIS II GSD2B, FORMERLY VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY, FORMERLY ANTOPOL DISEASE Danon disease GSD IIb, FORMERLY Lysosomal glycogen storage disease with normal acid maltase activity Glycogenosis due to LAMP-2 deficiency GSD due to LAMP-2 deficiency GLYCOGEN STORAGE DISEASE IIb |
Number of Symptoms | 53 |
OrphanetNr: | 34587 |
OMIM Id: |
300257
|
ICD-10: |
E74.0 |
UMLs: |
|
MeSH: |
|
MedDRA: |
|
Snomed: |
|
Prevalence, inheritance and age of onset:
Prevalence: | No data available. |
Inheritance: |
X-linked X-linked dominant - PMID: 25589223 [IBIS] |
Age of onset: |
Childhood - PMID: 25589223 [IBIS] |
Disease classification (adopted from Orphanet):
Parent Diseases: |
Glycogen storage disease
-Rare genetic disease Glycogen storage disease with hypertrophic cardiomyopathy -Rare cardiac disease -Rare genetic disease Lysosomal glycogen storage disease -Rare genetic disease Muscular glycogenosis -Rare genetic disease -Rare neurologic disease Syndromic neurometabolic disease with X-linked intellectual deficit -Rare genetic disease -Rare neurologic disease |
Comment:
Women present with clinical symptoms and events approximately 15 years after men and report a higher proportion of cognitive and skeletal muscle problems than previously recognized (PMID:21415759). The average age for the onset of Danon disease symptoms was 12.1 ± 6.5 years in men and 28.1 ± 15 years in women (PMID:25589223). |
Symptom Information:
|
(HPO:0000505) | Visual impairment | 17296900 | IBIS | 297 / 7739 | ||
|
(HPO:0007663) | Reduced visual acuity | 17296900 | IBIS | 100 / 7739 | ||
|
(HPO:0007814) | Retinal pigment epithelial mottling | 17296900 | IBIS | 5 / 7739 | ||
|
(HPO:0000512) | Abnormal electroretinogram | 17296900 | IBIS | 61 / 7739 | ||
|
(HPO:0000548) | Cone/cone-rod dystrophy | 17296900 | IBIS | 47 / 7739 | ||
|
(HPO:0007988) | Macular hypopigmentation | 17296900 | IBIS | 1 / 7739 | ||
|
(HPO:0001263) | Global developmental delay | 21161685 | IBIS | 853 / 7739 | ||
|
(HPO:0100543) | Cognitive impairment | Frequent [IBIS] | 21415759 | IBIS | 230 / 7739 | |
|
(HPO:0001249) | Intellectual disability | Frequent [IBIS] | 21415759 | IBIS | 1089 / 7739 | |
|
(HPO:0100749) | Chest pain | 21415759 | IBIS | 92 / 7739 | ||
|
(HPO:0001761) | Pes cavus | 15505188 | IBIS | 225 / 7739 | ||
|
(HPO:0004309) | Ventricular preexcitation | 21415759 | IBIS | 6 / 7739 | ||
|
(HPO:0001716) | Wolff-Parkinson-White syndrome | 21415759 | IBIS | 21 / 7739 | ||
|
(HPO:0001712) | Left ventricular hypertrophy | 19318653 | IBIS | 76 / 7739 | ||
|
(HPO:0001639) | Hypertrophic cardiomyopathy | Very frequent [IBIS] | 25589223 | IBIS | 137 / 7739 | |
|
(HPO:0001700) | Myocardial necrosis | 15889279 | IBIS | 6 / 7739 | ||
|
(HPO:0001695) | Cardiac arrest | 19318653 | IBIS | 87 / 7739 | ||
|
(HPO:0001962) | Palpitations | 21415759 | IBIS | 62 / 7739 | ||
|
(HPO:0011675) | Arrhythmia | 21415759 | IBIS | 226 / 7739 | ||
|
(HPO:0001644) | Dilated cardiomyopathy | 21415759 | IBIS | 141 / 7739 | ||
|
(HPO:0001638) | Cardiomyopathy | Very frequent [Orphanet] | 25589223 | IBIS | 192 / 7739 | |
|
(HPO:0012664) | Reduced ejection fraction | 19318653 | IBIS | 32 / 7739 | ||
|
(HPO:0001640) | Cardiomegaly | 19318653 | IBIS | 81 / 7739 | ||
|
(HPO:0001685) | Myocardial fibrosis | 15889279 | IBIS | 30 / 7739 | ||
|
(HPO:0000822) | Hypertension | 21415759 | IBIS | 224 / 7739 | ||
|
(HPO:0006670) | Impaired myocardial contractility | 17849364 | IBIS | 9 / 7739 | ||
|
(HPO:0004756) | Ventricular tachycardia | 21415759 | IBIS | 55 / 7739 | ||
|
(HPO:0003236) | Elevated serum creatine phosphokinase | 21415759 | IBIS | 214 / 7739 | ||
|
(HPO:0003077) | Hyperlipidemia | 21415759 | IBIS | 37 / 7739 | ||
|
(HPO:0002093) | Respiratory insufficiency | 21415759 | IBIS | 410 / 7739 | ||
|
(HPO:0001324) | Muscle weakness | Very frequent [Orphanet] | 25589223 | IBIS | 859 / 7739 | |
|
(HPO:0003715) | Myofibrillar myopathy | 25589223 | IBIS | 9 / 7739 | ||
|
(HPO:0003736) | Autophagic vacuoles | Very frequent [IBIS] | 25589223 | IBIS | 5 / 7739 | |
|
(HPO:0003546) | Exercise intolerance | 21161685 | IBIS | 62 / 7739 | ||
|
(HPO:0003710) | Exercise-induced muscle cramps | 21415759 | IBIS | 11 / 7739 | ||
|
(HPO:0003202) | Skeletal muscle atrophy | 25589223 | IBIS | 281 / 7739 | ||
|
(HPO:0003701) | Proximal muscle weakness | 25589223 | IBIS | 105 / 7739 | ||
|
(HPO:0003458) | EMG: myopathic abnormalities | 16372318 | IBIS | 38 / 7739 | ||
|
(OMIM) | Cardiomyocytes show glycogen accumulation in myofibrils and lysosomes | 25589223 | IBIS | 1 / 7739 | ||
|
(OMIM) | Positive staining for complement C5b-9 membrane attack complex proteins within vacuoles, but not on muscle fiber membrane | 15792868 | IBIS | 1 / 7739 | ||
|
(OMIM) | Indentations or folds of the sarcolemma are connected to the membranes enclosing the vacuoles | 25589223 | IBIS | 1 / 7739 | ||
|
(OMIM) | Near complete loss of peripheral retinal pigment in males | 16751040 | IBIS | 1 / 7739 | ||
|
(HPO:0030231) | Glycogen accumulation in muscle fiber lysosomes | 25589223 | IBIS | 1 / 7739 | ||
|
(HPO:0011813) | Increased cerebral lipofuscin | 25589223 | IBIS | 4 / 7739 | ||
|
(OMIM) | Cardiomyocytes have irregular nuclei | 15792868 | IBIS | 1 / 7739 | ||
|
(OMIM) | Severely decreased or absent LAMP2 protein | 21415759 | IBIS | 1 / 7739 | ||
|
(OMIM) | Cardiomyocytes contain vacuolated cytoplasm with degenerated mitochondria, glycogen, and granular debris | 15792868 | IBIS | 1 / 7739 | ||
|
(OMIM) | Vacuolar membranes immunostain with sarcolemmal proteins | 25589223 | IBIS | 1 / 7739 | ||
|
(OMIM) | Muscle biopsy shows sarcoplasmic PAS-positive vacuoles | 15253947 | IBIS | 1 / 7739 | ||
|
(OMIM) | Cognitive impairment, mild | 21415759 | IBIS | 15 / 7739 | ||
|
(HPO:0012758) | Neurodevelopmental delay | Very frequent [Orphanet] | 25589223 | IBIS | 949 / 7739 | |
|
(OMIM) | Normal alpha-glucosidase or acid maltase activity (GAA, 606800) | 25589223 | IBIS | 3 / 7739 | ||
|
(HPO:0003812) | Phenotypic variability | 21161685 | IBIS | 129 / 7739 |
Associated genes:
LAMP2; |
ClinVar (via SNiPA)
Gene symbol | Variation | Clinical significance | Reference |
---|---|---|---|
LAMP2 | rs104894857 | pathogenic | RCV000010662.3 |
LAMP2 | rs104894858 | pathogenic | RCV000010663.3 |
LAMP2 | rs104894859 | pathogenic | RCV000010664.4 |
LAMP2 | rs137852527 | pathogenic | RCV000010655.4 |
LAMP2 | rs193922649 | likely pathogenic | RCV000037418.2 |
LAMP2 | rs397516736 | likely pathogenic | RCV000037408.2 |
LAMP2 | rs397516736 | likely pathogenic | RCV000037407.2 |
LAMP2 | rs397516738 | likely pathogenic | RCV000037410.2 |
LAMP2 | rs397516739 | likely pathogenic | RCV000037411.2 |
LAMP2 | rs397516740 | likely pathogenic | RCV000037412.2 |
LAMP2 | rs397516743 | pathogenic | RCV000037416.2 |
LAMP2 | rs397516751 | likely pathogenic | RCV000037432.2 |
LAMP2 | rs397516752 | likely pathogenic | RCV000037433.2 |
LAMP2 | rs727503118 | pathogenic | RCV000150911.1 |
LAMP2 | rs727503119 | pathogenic | RCV000150912.1 |
LAMP2 | rs727503120 | likely pathogenic | RCV000150913.1 |
LAMP2 | rs727504262 | likely pathogenic | RCV000154245.1 |
LAMP2 | rs727504557 | likely pathogenic | RCV000155721.1 |
LAMP2 | rs727504597 | pathogenic | RCV000155777.1 |
LAMP2 | rs727504600 | pathogenic | RCV000155846.1 |
LAMP2 | rs727504648 | pathogenic | RCV000155911.1 |
LAMP2 | rs727504742 | pathogenic | RCV000156041.1 |
LAMP2 | rs730880344 | likely pathogenic | RCV000154670.1 |
Additional Information:
Description: (OMIM) |
Danon disease is an X-linked dominant disorder predominantly affecting cardiac muscle. Skeletal muscle involvement and mental retardation are variable features. The accumulation of glycogen in muscle and lysosomes originally led to the classification of Danon disease as a ... |
Clinical Description OMIM |
Antopol et al. (1940) described 2 brothers who died in the second decade of life with heart failure. Autopsy of 1 patient showed glycogen storage disease limited to the myocardium. Mehrizi and Oppenheimer (1960) reported 2 related patients ... |
Genotype-Phenotype Correlations OMIM |
In a male patient with hypertrophic cardiomyopathy, exercise intolerance, and hyperCKemia consistent with a mild form of Danon disease, Musumeci et al. (2005) identified a missense mutation in the LAMP2 gene (309060.0011). The patient did not have muscle ... |
Molecular genetics OMIM |
In 10 unrelated patients with Danon disease, Nishino et al. (2000) identified 10 different mutations in the LAMP2 gene (see, e.g., 309060.0001-309060.0006). All of the mutations resulted in premature termination of the LAMP2 protein. Several patients had previously ... |